In January 2024, Palantir Technologies experienced a 15% decline as software sector beta pressures weighed on its shares. Despite that early-year weakness, PLTR rallied strongly over the next eleven months, finishing the year up 340%. The rebound was underpinned by accelerating enterprise AI deployments in the U.S., where commercial contract value surpassed $1 billion for the first time in Q3 2024. Insider buying during the January dip—executives disclosed purchases totaling $12 million in stock—reinforced confidence that the recent lower price levels presented a buying opportunity for long-term investors.

Following a 20% post-Q3 selloff, which many attributed to broader software sector volatility rather than company-specific weakness, Palantir heads into its February 2, 2026 earnings report with expectations for triple-digit year-over-year revenue growth. Street consensus models project Q4 revenue of $620 million, up 105% from Q4 2024, while adjusted EBITDA margins are forecast to improve by 500 basis points to 30%. Should management’s guidance exceed these estimates, the stock could be re-rated from its current 109.3x price-to-sales multiple, particularly as AI adoption continues to accelerate commercial bookings.

An analysis of Palantir’s past seven quarterly reports reveals that the stock advanced five times and declined twice in the two weeks following earnings announcements. Notably, after the Q2 2024 results—when commercial revenues grew 120% year-over-year—shares jumped 18% over the subsequent ten trading days. That pattern underscores investor sensitivity to AI platform traction: every quarter in which Palantir reported more than $300 million in new AI-related contracts since Q1 2024, the stock saw an average post-earnings gain of 12%. However, in two quarters where guidance fell short by at least 5% of consensus, shares declined an average of 8%.

Palantir’s robust cash position of $6.44 billion and zero debt supports its elevated valuation, yet maintaining the ‘Rule of 80’—combined revenue growth plus adjusted EBITDA margin above 80%—will be critical to justify further multiple expansion. An EV/EBITDA approach yields a base-case price target of $184, representing roughly 11% upside from current levels, assuming 100% revenue growth and 32% EBITDA margins in FY 2026. Primary risks include potential softening in U.S. commercial procurement cycles and geopolitical headwinds affecting international defense contracts, given the company’s pro-U.S. stance and exposure to sensitive government data analytics projects.